🎯 3 free searches remaining
Organigram Holdings Inc. produces and sells cannabis and cannabis-derived products in Canada. The company shows strengths in its solid gross margin of 36.7% and a strong liquidity position with a current ratio of 2.73, indicating good short-term financial health. However, the low EBITDA margin of 2.5% raises concerns about profitability despite a high net margin of 31.4%. The absence of debt is positive, but the overall market cap of $235.14M suggests potential undervaluation given its strong margins.
Loading financial metrics...
Company has $7.6M in cash but burned $4.9M last quarter. At this burn rate, only 1.6 quarters of runway remain without additional financing.
Exceptional revenue growth of 68.6% YoY demonstrates strong market demand and competitive positioning.
Gross margin expanded by 6.9 percentage points, indicating improved pricing power or cost efficiency.
Operating margin expanded by 21.1pp, demonstrating strong operational leverage.
Both gross margin (+6.9pp) and operating margin (+21.1pp) are expanding simultaneously, indicating the company is scaling profitably.
Fortress balance sheet with cash exceeding debt by Infinity%, providing significant financial flexibility.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.